Xenon Pharmaceuticals Inc.

XENENasdaq· Pharmaceutical Preparations

Price History

Revenue

$7.5M

Net Income

-$345.9M

▼ 47.6% YoY

EPS

$-4.36

▼ 44.9% YoY

Cash

$199.2M

▲ 39.6% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.